Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1987-04-06
1990-02-13
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530363, 530380, 530381, 530382, 530387, 530385, 530393, 530394, 530350, A61K 3702, A61K 3704, A61K 3762, A61K 3516
Patent
active
049007203
ABSTRACT:
To maintain an almost unchanged plasma-protein profile in a patient subsequent to plasma exchange, the plasma-exchange medium contains the most essential human serum proteins, except for the coagulation factors, at a concentration of 75 g/l.
REFERENCES:
patent: 4025500 (1977-05-01), Garcia et al.
patent: 4170590 (1979-10-01), Stephan et al.
patent: 4271122 (1981-06-01), Strassle et al.
patent: 4272523 (1981-06-01), Kotitschke et al.
patent: 4370264 (1983-01-01), Kotitschke et al.
patent: 4503030 (1985-03-01), Kotitschke et al.
patent: 4656254 (1987-04-01), Shearer et al.
patent: 4697003 (1987-09-01), Loan
Stedeman's Medical Dictionary, pp. 1664-1671, (1982), Waverly Press, Hensyl (Editor).
Boitest Pharma GmbH
Kushan Jeff
Moskowitz Margaret
LandOfFree
Replacement of human plasma using sterile solution of human plas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Replacement of human plasma using sterile solution of human plas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Replacement of human plasma using sterile solution of human plas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1168225